Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Since the discovery of cell-free DNA (cfDNA) in 1948, shedded DNA fragments have been applied to technologies ranging from pre-natal genetic screening and ...

The Lumina project aims to deliver an advanced Minimal Residual Disease (MRD) detection platform for lung cancer. Harnessing ...

A new screening method that combines laser analysis with ... Machine Learning, and Liquid Biopsy for Personalised Diagnostics, Journal of Biophotonics (2024). DOI: 10.1002/jbio.

The most significant benefit of a liquid biopsy is that it requires only a blood draw or other fluid collection. There is no invasive procedure or surgery, which are sometimes required to collect a ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

Since its first event, staged in a classroom with 50 donors, the downtown hospital fundraiser has cracked the elusive code ...

Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer. The company is announcing ...

The study's findings indicate that the new screening method could recognize the first signals of cancer with an effectiveness ...

The team showed promising ... Ultrasensitive Liquid Biopsy Tech Spots Cancer Earlier Than Standard Methods June 14, 2024 — An artificial intelligence-powered method for detecting tumor DNA in ...